Stocks · Health care · Biological Products, (No Diagnostic Substances)

NEUROCRINE BIOSCIENCES INC

NBIX Clue Score82
United States Fiscal year ends December CIK 0000914475 Results filed 2 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
George J Morrow
3 Nov 2026
Director
Sold after exercise
1,300
$168.53
$219.09K
George J Morrow
3 Nov 2026
Director
Sold after exercise
1,500
$167.72
$251.59K
George J Morrow
3 Nov 2026
Director
Sold after exercise
1,466
$166.77
$244.49K
George J Morrow
3 Nov 2026
Director
Sold after exercise
908
$165.71
$150.46K
George J Morrow
3 Nov 2026
Director
Sold after exercise
1,226
$164.74
$201.97K
George J Morrow
3 Nov 2026
Director
Sold after exercise
600
$163.71
$98.22K
George J Morrow
3 Nov 2026
Director
Sold after exercise
100
$162.05
$16.21K
George J Morrow
3 Nov 2026
Director
Sold after exercise
100
$158.18
$15.82K
George J Morrow
2 Nov 2026
Director
Sold after exercise
1,300
$146.76
$190.78K
George J Morrow
2 Nov 2026
Director
Sold after exercise
4,300
$145.86
$627.19K
George J Morrow
2 Nov 2026
Director
Sold after exercise
1,900
$144.98
$275.45K
George J Morrow
30 Oct 2026
Director
Sold after exercise
300
$149.00
$44.70K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 12
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 15,946
History held since 16 Jan 2007